510(k) Report

510(k) · Cleared

Cleared

hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS

K190496510(k) TraditionalCleared Apr 24, 201955-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cefla S.C. · OAS X-Ray, Tomography, Computed, Dental

Cleared on Apr 24, 2019 after a 55-day review. The FDA summary names no predicate by number. 4 later devices descend from it.

Decided
Apr 24, 2019
Review
55 days
Class
Class II
Product code
OAS
Recalls
None
Predicates
0

4 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2020: 1 descendant cleared2022: 1 descendant cleared2026: 1 descendant cleared2023: 1 descendant cleared201620182020202220242026
  1. This deviceK190496 hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2019
  2. Descendant · cites it directly · 1 of its ownK214084 hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2022
  3. Descendant · cites it directly · 1 of its ownK200688 hyperion X5, NewTom GO, X-RADiUS COMPACTCefla S.C. · 2020
  4. Descendant · 2 generations on · 0 of its ownK252353 myray ProXIma X6Cefla S.C. · 2026
  5. Descendant · 2 generations on · 0 of its ownK223794 hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2023

Most influential descendants

Showing 4 of 4 · See all
  • K214084hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2022 · cites it directly1descendant
  • K200688hyperion X5, NewTom GO, X-RADiUS COMPACTCefla S.C. · 2020 · cites it directly1descendant
  • K252353myray ProXIma X6Cefla S.C. · 2026 · 2 generations on0descendants
  • K223794hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C. · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K190496hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.2019—
+1K214084hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.2022—
+1K200688hyperion X5, NewTom GO, X-RADiUS COMPACTCefla S.C.2020—
+2K252353myray ProXIma X6Cefla S.C.2026—
+2K223794hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.2023—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202210
202310
202610
FIG. 1 — Lineage of K190496, 2019–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OAS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OAS device

  1. #1 K213226 RCT700score 18.0 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K214084hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUSCefla S.C.20221
K200688hyperion X5, NewTom GO, X-RADiUS COMPACTCefla S.C.20201

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K214084 (Cefla S.C., 2022) has gone furthest, with 1 descendant of its own.

How does its category compare?

All OAS devices

OAS X-Ray, Tomography, Computed, Dental: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · OAS

9in 2025

2007: 22008: 22009: 22010: 12011: 62012: 72013: 102014: 52015: 52016: 122017: 42018: 112019: 72020: 92021: 112022: 62023: 122024: 42025: 92026 (partial year): 9
2007high 12 (2016) · low 1 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OAS

144in 2025

2011: 168 days median2012: 110 days median2013: 155 days median2014: 170 days median2015: 164 days median2016: 154 days median2017: 209 days median2018: 57 days median2019: 55 days median2020: 113 days median2021: 92 days median2022: 105 days median2023: 77 days median2024: 129 days median2025: 144 days median2026 (partial year): 77 days median
2007high 209 (2017) · low 55 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OAS

3in 2025

2015: 12025: 3
2007high 3 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OAS

1in 2025

2008: 12019: 12022: 12023: 12024: 22025: 1
2007high 2 (2024) · low 0 (2007)2025

MAUDE reports naming product code OAS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—01
20092—00
20101—00
2011616800
2012711000
20131015500
2014517000
2015516410
20161215400
2017420900
2018115700
201975501
2020911300
2021119200
2022610501
2023127701
2024412902
2025914431
20269770—

What is it indicated for?

hyperion X9 pro, NewTom Giano HR, X-RADiUS TRiO PLUS is a digital panoramic, cephalometric and tomographic extra-oral X-ray system, intended to: (I) produce orthopanoramic images of the maxillofacial region and carry out diagnostic examination on teeth, dental arches and other structures in the oral cavity; (II) produce radiographs of jaws, parts of the skull and carpus for the purpose of cephalometric examination, when equipped with tele-radiographic…

Read the full statement (136 words)

hyperion X9 pro, NewTom Giano HR, X-RADiUS TRiO PLUS is a digital panoramic, cephalometric and tomographic extra-oral X-ray system, intended to:

(I) produce orthopanoramic images of the maxillofacial region and carry out diagnostic examination on teeth, dental arches and other structures in the oral cavity;

(II) produce radiographs of jaws, parts of the skull and carpus for the purpose of cephalometric examination, when equipped with tele-radiographic arm (CEPH);

(III) the production of tomographic images of the head, including the ear, nose and throat (ENT), of the dento-maxillo-facial complex, teeth, mandible and maxilla, temporomandibular-articular joint (TMJ), other areas of the human skull and neck with sections of the cervical spine for use in diagnostic support, if equipped with the CBCT option.

The device is operated and used by physicians, dentists, x-ray technologists and other legally qualified professionals.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K190496: hyperion X9 pro, NewTom GiANO HR, X-RADiUS TRiO PLUS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K190496

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026